Clinical Trial Update: A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

View source ↗

Summary

This entry notes the completion of a clinical trial in China evaluating treatment patterns among patients with moderate-to-severe asthma, sponsored by AstraZene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Moderate-to-Severe Asthma | Status: COMPLETED